Take a look around.
Bayer's Stivarga® (regorafenib) becomes first compound used in clinical trial platform to investigate new therapies for brain cancer
Bayer announced today that the Stivarga® (regorafenib) arm of the platform trial GBM AGILE (Glioblastoma Adaptive Global Innovative Learning Environment) has opened enrollment for patients with...Learn more
Bayer Donation of $45,000 Helped Fund Development of Cook Museum of Natural Science
The Environmental Science business of Bayer is honored to have contributed $45,000 toward the development of the new Cook Museum of Natural Science that opened on June 7 in Decatur, AL. The museum...Learn more
Explore Our Divisions
In line with our mission “Bayer: Science for A Better Life,” we aim to improve people’s quality of life.